SourceMDx's Unattributed VC Round

SourceMDx raised a round of funding on February 08, 2010. Investors include Pfizer Venture Investments.

Source MDx is developing and commercializing prognostic, predictive and early detection molecular diagnostic (Precision Profile ) assays and tests for cancer and other inflammatory diseases. The compa…

Articles about SourceMDx's Unattributed VC Round: